Editorial & Advertiser disclosure

Global Banking & Finance Review® is an online platform offering news, analysis, and opinion on the latest trends, developments, and innovations in the banking and finance industry worldwide. The platform covers a diverse range of topics, including banking, insurance, investment, wealth management, fintech, and regulatory issues. The website publishes news, press releases, opinion and advertorials on various financial organizations, products and services which are commissioned from various Companies, Organizations, PR agencies, Bloggers etc. These commissioned articles are commercial in nature. This is not to be considered as financial advice and should be considered only for information purposes. It does not reflect the views or opinion of our website and is not to be considered an endorsement or a recommendation. We cannot guarantee the accuracy or applicability of any information provided with respect to your individual or personal circumstances. Please seek Professional advice from a qualified professional before making any financial decisions. We link to various third-party websites, affiliate sales networks, and to our advertising partners websites. When you view or click on certain links available on our articles, our partners may compensate us for displaying the content to you or make a purchase or fill a form. This will not incur any additional charges to you. To make things simpler for you to identity or distinguish advertised or sponsored articles or links, you may consider all articles or links hosted on our site as a commercial article placement. We will not be responsible for any loss you may suffer as a result of any omission or inaccuracy on the website.

Headlines

Bayer wins EU watchdog's endorsement for longer Eylea treatment intervals

Published by Global Banking & Finance Review

Posted on May 23, 2025

1 min read

· Last updated: January 23, 2026

Add as preferred source on Google

Bayer wins EU watchdog's endorsement for longer Eylea treatment intervals

innovation recommendations healthcare financial sector investment

Global Banking & Finance Awards 2026 — Call for Entries

(Reuters) -German drugmaker Bayer on Friday won an endorsement by the European Medicines Agency to extend the intervals between shots of its anti-blindness treatment Eylea, giving it a potential edge

Bayer Secures EU Approval for Extended Eylea Treatment Intervals

(Reuters) -German drugmaker Bayer on Friday won an endorsement by the European Medicines Agency to extend the intervals between shots of its anti-blindness treatment Eylea, giving it a potential edge over Roche's rival treatment Vabysmo.

Bayer said in a statement the European Medicines Agency recommended that eye drug Eylea, at a high dose of 8 mg, can be injected at intervals of up to six months to treat wet age-related macular degeneration and diabetic macular oedema.

(Reporting by Ludwig Burger, Editing by Friederike Heine)

Key Takeaways

Bayer received EU endorsement for longer Eylea treatment intervals.
The European Medicines Agency approved intervals of up to six months.
Eylea is used for wet age-related macular degeneration and diabetic macular oedema.
This approval may give Bayer an edge over Roche's Vabysmo.
The treatment involves a high dose of 8 mg.

Frequently Asked Questions

What did Bayer receive from the European Medicines Agency?

Bayer won an endorsement from the European Medicines Agency to extend the intervals between shots of its anti-blindness treatment Eylea.

What is the recommended interval for Eylea injections?

The European Medicines Agency recommended that Eylea, at a high dose of 8 mg, can be injected at intervals of up to six months.

What condition does Eylea treat?

Eylea is used to treat wet age-related macular degeneration, a condition that can lead to blindness.

More from Headlines

Explore more articles in the Headlines category

Pope Leo says those who wage war are thieves stealing away our peaceful future

King Charles relieved Trump and first lady unharmed after shooting

Northern Ireland police investigate car explosion as attempted murder

UK says cooperating closely with US on security ahead of King Charles' visit

Israeli attacks kill at least four Palestinians in Gaza, medics say

Six passengers injured evacuating from Swiss Air flight in India, Economic Times says

Trump removed from White House correspondents dinner as attendees take cover

Car explodes outside police station in Northern Ireland, Belfast Telegraph reports

US-Iran peace hopes fade as Trump scraps talks

Ukraine marks 40th anniversary of Chornobyl disaster under cloud of war

Russia's parliamentary speaker visits Pyongyang, KCNA says

Probe of stolen $1 billion should continue after conviction of Moldovan magnate, top official says

View All Headlines Posts

Bayer wins EU watchdog's endorsement for longer Eylea treatment intervals

Bayer Secures EU Approval for Extended Eylea Treatment Intervals

Key Takeaways

Frequently Asked Questions

Tags

Related Articles

Italy to extradite suspected Chinese hacker wanted by US authorities, says source

Soccer-Chelsea reach FA Cup final with 1-0 win over Leeds

Netanyahu's biggest rivals join forces for Israel's next election

Israel issues evacuation warning for seven Lebanese towns beyond 'buffer zone'

Athletics-Kenya's Sawe shatters elusive two-hour marathon barrier to win in London

UK's Starmer and Trump discuss 'urgent need' to restore shipping in Strait of Hormuz

More from Headlines